XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
 Psychiatry
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
 Respiratory Medicine
  Asthma
  COPD
  Cystic Fibrosis
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
Search

Last Updated: Aug 19th, 2006 - 22:18:38
Systematic Review

COPD Channel
subscribe to COPD newsletter

Latest Research : Respiratory Medicine : COPD

   DISCUSS   |   EMAIL   |   PRINT
Antibiotics reduce risk of dying from COPD attack by 77 percent
Jun 12, 2006, 20:21, Reviewed by: Dr. Sanjukta Acharya

"The review showed clearly that antibiotic therapy, regardless of which antibiotic was used, reduced the risks involved in an exacerbation, and as might be expected, the effects is greatest in patients with more severe disease,"

 
People with chronic obstructive pulmonary disease often experience short term worsening and aggravation of their symptoms. To date, there has been conflicting evidence as to whether these exacerbations should be treated with antibiotic therapy. A new systematic review to be published in The Cochrane Library, Issue 2, 2006 now concludes that they should be used. The researchers found that antibiotics reduce the risk of dying from the attack by 77%, decreases the risk of treatment failure by 53% and decrease the risk of developing pussy sputum by 44%. There is, however, a small increase in the risk of developing diarrhoea.

Many people question whether antibiotics should be used to combat exacerbations of COPD. The uncertainty stems from the growing desire to use antibiotics only when necessary, combined with the recognition that up to one third of exacerbations of COPD have are not caused by infections, and some others are due to viral infections.

A large number of trials have been conducted to try and address this situation, but a simple comparison suggests that the data is contradictory.

To clarify the situation the Cochrane Review Authors performed a systematic review of available data, and identified 11 trials involving 917 patients.

"The review showed clearly that antibiotic therapy, regardless of which antibiotic was used, reduced the risks involved in an exacerbation, and as might be expected, the effects is greatest in patients with more severe disease," says lead Review Author Dr Felix Ram, Senior Lecturer in Respiratory Medicine & Clinical Pharmacology in the School of Health Sciences, at Massey University in Auckland, New Zealand.

"The controversy over whether antibiotics should be prescribed to patients with acute exacerbations of COPD has been very highly debated and unsolved for many years in the respiratory field and this review will help to finally resolve this long outstanding issue in the management of our COPD patients," adds Dr Ram.
 

- Ram FSF et. al. Antibiotics for exacerbations of chronic obstructive pulmonary disease. The Cochrane Database of Systematic Reviews 2006, Issue 2. Art. No.: CD004403.pub2. DOI: 10.1002/14651858.CD004403.pub2.
 

www.cochrane.org

 
Subscribe to COPD Newsletter
E-mail Address:

 

The Cochrane Library contains high-quality, independent evidence to inform healthcare decision-making. It includes reliable evidence from Cochrane and other systematic reviews, clinical trials, and more. Cochrane reviews bring the combined results of the world’s best medical research studies, and are recognised as the gold standard in evidence-based healthcare.

Related COPD News

COPD patients using beta-agonist inhalers are at risk
Beta-agonists more than double death rate in COPD patients
Lung function test underused in patients with COPD
Wrinkles clue to risk of progressive lung disease (COPD)
Antibiotics reduce risk of dying from COPD attack by 77 percent
Women with chronic obstructive pulmonary disease (COPD) fare worse than men
Breathing Heliox 28 significantly improve the exercise performance in COPD
Combined treatment cuts inflammatory cells in chronic obstructive pulmonary disease
COPD is slated to become world's biggest killer by 2020 - WHO
Study Shows Benefits of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us